500 related articles for article (PubMed ID: 16216945)
1. Delayed neurotoxicity in primary central nervous system lymphoma.
Omuro AM; Ben-Porat LS; Panageas KS; Kim AK; Correa DD; Yahalom J; Deangelis LM; Abrey LE
Arch Neurol; 2005 Oct; 62(10):1595-600. PubMed ID: 16216945
[TBL] [Abstract][Full Text] [Related]
2. Characteristics and outcomes of elderly patients with primary central nervous system lymphoma: the Memorial Sloan-Kettering Cancer Center experience.
Ney DE; Reiner AS; Panageas KS; Brown HS; DeAngelis LM; Abrey LE
Cancer; 2010 Oct; 116(19):4605-12. PubMed ID: 20572045
[TBL] [Abstract][Full Text] [Related]
3. High-dose thiotepa, busulfan, cyclophosphamide and ASCT without whole-brain radiotherapy for poor prognosis primary CNS lymphoma.
Cheng T; Forsyth P; Chaudhry A; Morris D; Glück S; Russell JA; Stewart DA
Bone Marrow Transplant; 2003 Apr; 31(8):679-85. PubMed ID: 12692608
[TBL] [Abstract][Full Text] [Related]
4. Increasing incidence and continued dismal outcome of primary central nervous system lymphoma in Norway 1989-2003 : time trends in a 15-year national survey.
Haldorsen IS; Krossnes BK; Aarseth JH; Scheie D; Johannesen TB; Mella O; Espeland A
Cancer; 2007 Oct; 110(8):1803-14. PubMed ID: 17721992
[TBL] [Abstract][Full Text] [Related]
5. Cognitive performance and magnetic resonance imaging findings after high-dose systemic and intraventricular chemotherapy for primary central nervous system lymphoma.
Fliessbach K; Urbach H; Helmstaedter C; Pels H; Glasmacher A; Kraus JA; Klockgether T; Schmidt-Wolf I; Schlegel U
Arch Neurol; 2003 Apr; 60(4):563-8. PubMed ID: 12707070
[TBL] [Abstract][Full Text] [Related]
6. Salvage whole brain radiotherapy for recurrent or refractory primary CNS lymphoma.
Hottinger AF; DeAngelis LM; Yahalom J; Abrey LE
Neurology; 2007 Sep; 69(11):1178-82. PubMed ID: 17846417
[TBL] [Abstract][Full Text] [Related]
7. Patterns of treatment in older adults with primary central nervous system lymphoma.
Panageas KS; Elkin EB; Ben-Porat L; Deangelis LM; Abrey LE
Cancer; 2007 Sep; 110(6):1338-44. PubMed ID: 17647247
[TBL] [Abstract][Full Text] [Related]
8. Primary central nervous system lymphoma: the role of consolidation treatment after a complete response to high-dose methotrexate-based chemotherapy.
Ekenel M; Iwamoto FM; Ben-Porat LS; Panageas KS; Yahalom J; DeAngelis LM; Abrey LE
Cancer; 2008 Sep; 113(5):1025-31. PubMed ID: 18618509
[TBL] [Abstract][Full Text] [Related]
9. Primary CNS lymphoma treated with combined intra-arterial ACNU and radiotherapy.
Sonoda Y; Matsumoto K; Kakuto Y; Nishino Y; Kumabe T; Tominaga T; Katakura R
Acta Neurochir (Wien); 2007 Nov; 149(11):1183-9; discussion 1189. PubMed ID: 17712511
[TBL] [Abstract][Full Text] [Related]
10. Primary central nervous system lymphoma: the Memorial Sloan-Kettering Cancer Center prognostic model.
Abrey LE; Ben-Porat L; Panageas KS; Yahalom J; Berkey B; Curran W; Schultz C; Leibel S; Nelson D; Mehta M; DeAngelis LM
J Clin Oncol; 2006 Dec; 24(36):5711-5. PubMed ID: 17116938
[TBL] [Abstract][Full Text] [Related]
11. Neuropsychological outcome after chemotherapy for primary CNS lymphoma: a prospective study.
Fliessbach K; Helmstaedter C; Urbach H; Althaus A; Pels H; Linnebank M; Juergens A; Glasmacher A; Schmidt-Wolf IG; Klockgether T; Schlegel U
Neurology; 2005 Apr; 64(7):1184-8. PubMed ID: 15824344
[TBL] [Abstract][Full Text] [Related]
12. [Primary central nervous system lymphoma--a report of 32 cases with literature review].
Yi JQ; Lin TY; He YJ; Huang HQ; Xia ZJ; Xia YF; Xu RH; Guo Y; Guan ZZ
Ai Zheng; 2006 Apr; 25(4):476-80. PubMed ID: 16613684
[TBL] [Abstract][Full Text] [Related]
13. Long-term follow-up of high-dose methotrexate-based therapy with and without whole brain irradiation for newly diagnosed primary CNS lymphoma.
Gavrilovic IT; Hormigo A; Yahalom J; DeAngelis LM; Abrey LE
J Clin Oncol; 2006 Oct; 24(28):4570-4. PubMed ID: 17008697
[TBL] [Abstract][Full Text] [Related]
14. Human immunodeficiency virus-related primary central nervous system lymphoma: factors influencing survival in 111 patients.
Newell ME; Hoy JF; Cooper SG; DeGraaff B; Grulich AE; Bryant M; Millar JL; Brew BJ; Quinn DI
Cancer; 2004 Jun; 100(12):2627-36. PubMed ID: 15197806
[TBL] [Abstract][Full Text] [Related]
15. [Treatment of primary central nervous system lymphoma in the immunocompetent patient].
Sierra Del Rio M; Benouaich-Amiel A; Psimaras D; Dehais C; Hoang-Xuan K
Rev Neurol (Paris); 2008; 164(6-7):569-74. PubMed ID: 18565356
[TBL] [Abstract][Full Text] [Related]
16. [Depression and frontal dysfunction: risks for the elderly?].
Thomas P; Hazif Thomas C; Billon R; Peix R; Faugeron P; Clément JP
Encephale; 2009 Sep; 35(4):361-9. PubMed ID: 19748373
[TBL] [Abstract][Full Text] [Related]
17. Primary CNS lymphoma.
Gerstner E; Batchelor T
Expert Rev Anticancer Ther; 2007 May; 7(5):689-700. PubMed ID: 17492932
[TBL] [Abstract][Full Text] [Related]
18. Delayed effects of whole brain radiotherapy in germ cell tumor patients with central nervous system metastases.
Doyle DM; Einhorn LH
Int J Radiat Oncol Biol Phys; 2008 Apr; 70(5):1361-4. PubMed ID: 18374223
[TBL] [Abstract][Full Text] [Related]
19. Advances for the treatment of primary central nervous system lymphoma (review).
Yamanaka R; Tanaka R
Oncol Rep; 2004 Sep; 12(3):563-8. PubMed ID: 15289838
[TBL] [Abstract][Full Text] [Related]
20. Current management of primary central nervous system lymphoma.
Schultz CJ; Bovi J
Int J Radiat Oncol Biol Phys; 2010 Mar; 76(3):666-78. PubMed ID: 20159361
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]